Vagina Pelvis Extra-Pelvic
GOG-99: Observation Group (n=202) 13 (6.4%) 5 (2.5%) 13 (6.4%)
GOG-99: Radiotherapy Group (n=190) 2 (1.1%) 1 (0.5%) 10 (5.3%)
PORTEC-1: Observation Group (n=360) 30 (8.3%) 10 (3.6%) 20 (5.6%)
PORTEC-1: Radiotherapy Group (n=354) 7 (2.0%) 4 (1.1%) 24 (6.8%)
Table 3: Sites of Endometrial Cancer Recurrence.